HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Hong Chen Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

12/2021Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis.
1/2019FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Hong Chen Research Topics

Disease

40Leukemia
05/2024 - 04/2006
34Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024 - 04/2006
27Residual Neoplasm
01/2022 - 07/2008
21Infections
03/2024 - 12/2004
19Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 06/2012
15Neoplasms (Cancer)
05/2024 - 07/2008
15Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 01/2011
12Aplastic Anemia (Anemia, Hypoplastic)
01/2023 - 04/2004
11Hematologic Neoplasms (Hematological Malignancy)
11/2021 - 07/2008
9Bronchiolitis Obliterans Syndrome
11/2023 - 01/2010
9Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020 - 08/2008
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016 - 08/2008
7Philadelphia Chromosome
10/2022 - 01/2011
6Thrombocytopenia (Thrombopenia)
12/2021 - 10/2015
5Hematologic Diseases (Blood Diseases)
11/2020 - 08/2009
4Cytomegalovirus Infections (Inclusion Disease)
01/2022 - 06/2007
4Thrombotic Microangiopathies
01/2022 - 04/2006
4Viremia
10/2017 - 01/2007
3Hepatitis
03/2024 - 04/2008
3Sepsis (Septicemia)
12/2023 - 01/2021
3Hemorrhage
01/2022 - 01/2007
3Pneumonia (Pneumonitis)
10/2021 - 06/2009
3Hemorrhagic Cystitis
07/2018 - 01/2007
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2015 - 12/2007
2Open-Angle Glaucoma (Glaucoma, Open Angle)
04/2024 - 01/2024
2Heart Failure
01/2023 - 09/2013
2Neoplasm Metastasis (Metastasis)
12/2021 - 10/2021
2Triple Negative Breast Neoplasms
11/2021 - 01/2020
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2021 - 05/2012
2Stroke (Strokes)
01/2021 - 11/2020
2Disease Progression
01/2021 - 01/2019
2Carcinogenesis
01/2021 - 01/2019
2Inflammation (Inflammations)
01/2021 - 03/2011
2Melanoma (Melanoma, Malignant)
01/2019 - 08/2016
2Demyelinating Diseases (Demyelinating Disease)
08/2018 - 03/2013
1Pathologic Complete Response
05/2024
1Chronic Hepatitis B
03/2024
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2024
1Discoid Lupus Erythematosus
02/2024
1Alopecia (Baldness)
02/2024
1Ocular Hypertension (Glaucoma, Suspect)
01/2024
1Septic Shock (Toxic Shock Syndrome)
12/2023
1Mental Disorders (Mental Disorder)
09/2023
1Herpes Zoster
09/2023
1Sleep Initiation and Maintenance Disorders (Insomnia)
09/2023

Drug/Important Bio-Agent (IBA)

13HLA Antigens (Human Leukocyte Antigens)IBA
12/2022 - 05/2008
7InterferonsIBA
01/2022 - 11/2015
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 04/2004
5SteroidsIBA
01/2024 - 01/2019
4Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2016
4BasiliximabFDA Link
01/2024 - 01/2020
4BilirubinIBA
12/2023 - 12/2021
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 01/2016
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 03/2011
3Prostaglandins FIBA
05/2024 - 10/2015
3AntigensIBA
03/2024 - 08/2016
3Immunosuppressive Agents (Immunosuppressants)IBA
09/2023 - 05/2008
3Antiviral Agents (Antivirals)IBA
09/2023 - 01/2021
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2023 - 08/2017
3Phosphotransferases (Kinase)IBA
12/2021 - 01/2019
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 08/2008
3Immunoglobulin G (IgG)IBA
01/2019 - 08/2018
3Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 01/2011
2C-Reactive ProteinIBA
01/2023 - 02/2017
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2023 - 01/2023
2Tyrosine Kinase InhibitorsIBA
10/2022 - 01/2019
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2021 - 01/2019
2CytokinesIBA
10/2021 - 01/2021
2Therapeutic UsesIBA
01/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2021
2AntibodiesIBA
11/2020 - 01/2019
2MethylprednisoloneFDA LinkGeneric
01/2019 - 08/2011
2HLA-B Antigens (HLA-B)IBA
01/2019 - 03/2012
2Methotrexate (Mexate)FDA LinkGeneric
08/2011 - 07/2008
2Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2008 - 07/2008
1GW 501516IBA
05/2024
1erucylphosphocholineIBA
05/2024
1MicroRNAs (MicroRNA)IBA
04/2024
1Indicators and Reagents (Reagents)IBA
03/2024
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2024
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2024
1Peroxynitrous Acid (Peroxynitrite)IBA
01/2024
1Mn(III) 5,10,15,20- tetrakis(N- methylpyridinium- 2- yl)porphyrinIBA
01/2024
1Lactic Acid (Lactate)FDA LinkGeneric
12/2023
1AlbuminsIBA
12/2023

Therapy/Procedure

103Hematopoietic Stem Cell Transplantation
01/2024 - 01/2007
41Transplantation
12/2023 - 04/2004
25Therapeutics
05/2024 - 01/2007
21Stem Cell Transplantation
01/2023 - 06/2012
13Drug Therapy (Chemotherapy)
05/2024 - 12/2007
6Cell Transplantation
10/2022 - 04/2006
6Immunotherapy
01/2022 - 08/2016
5Haploidentical Transplantation
01/2021 - 01/2016
2Catheters
01/2023 - 08/2016
2Homologous Transplantation
01/2023 - 01/2022
2Aftercare (After-Treatment)
01/2021 - 11/2018
2Consolidation Chemotherapy
03/2019 - 01/2016
2Induction Chemotherapy
12/2016 - 01/2016
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2013 - 02/2009
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2023